Members of the CIVP appointed
The Consiglio di Sorveglianza of the Human Technopole Foundation has appointed eight experts with proven professional qualifications to form the Standing Independent Evaluation Committee (CIVP).
In view of the upcoming opening of the National Facilities, the CIVP’s task will be to assess and approve the applications for access to the Facilities. During its first meetings, the CIVP will therefore elaborate the selection procedures for the access to the Facilities, including the criteria for the evaluation and selection of access requests, according to international best practices.
The members selected and appointed by the Consiglio di Sorveglianza of the HT Foundation, which also include the ex officio member Walter Ricciardi Chairman of Human Technopole’s Scientific Committee, are (in alphabetic order):
Professor Juha Kere, Professor of Molecular Genetics, Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden
Professor Filippo Mancia, Professor of Physiology and Cellular Biophysics, Department of Physiology & Cellular Biophysics, Columbia University, New York, U.S.A.
Professor Samuele Marro, Associate Professor of Neuroscience and co-Director of the Stem Cell Engineering Core, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, U.S.A.
Dr. Jan Peychl, Senior Service Leader, Light Microscopy Facility, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany
Professor Giampietro Schiavo, Professor of Neuroscience, Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, UK
Professor Maria Secrier, Associate Professor of Computational Cancer Biology, Genetics Institute, Department of Genetics, Evolution and Environment, University College London, UK
Professor Arianna Tucci, Associate Professor of Medical Genomics, Queen Mary University of London, UK
Dr. Virginie Uhlmann, Group Leader, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK and Director of the BioVisionCenter, University of Zurich, CH
The members of the SIEC were selected following the publication of a public notice for the pre-selection of candidates for the establishment of the Committee on 4 July 2023. The Consiglio di Sorveglianza of the HT Foundation received the list of pre-selected candidates from the Ministry of University and Research and the Ministry of Health.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.